At the news
? NEUTRALIMPACT 2/10 144 filed Jun 15, 2026 at 16:58 ET
Director William J. Link filed a Form 144 notice of intent to sell 12,500 shares of Tarsus Pharmaceuticals common stock, valued at approximately $776,497. This is a routine, small-scale sale by a non-executive director, representing less than 0.03% of the company's $2.7B market cap. The filing signals no material change in company fundamentals or insider sentiment.
- Director William J. Link (PhD) filed Form 144 to sell 12,500 shares of TARS common stock.
- Estimated sale value: $776,497.54 based on filing date price (~$62.12/share).
- Shares were acquired via stock option exercise on 01/10/2017.
- Sale is planned for on or after 06/15/2026, with Merrill Lynch as broker.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access